Study Of Cabaser and Sinemet CR For The Treatment Of Nighttime Symptoms Associated With Parkinson's Disease.

A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004

NCT02615873 ·Status: UNKNOWN ·Phase: PHASE3

eArly levoDopa With Opicapone in Parkinson's paTients wIth motOr fluctuatioNs.

NCT04990284 ·Status: COMPLETED ·Phase: PHASE4

Global REsponsE During iNFusIon of a gEl With LevoDopa/Carbidopa

NCT01754129 ·Status: COMPLETED

A Study to Assess Change in Sleep Disturbances of Adult Participants With Advanced Parkinson's Disease Receiving Subcutaneous Foslevodopa/Foscarbidopa

NCT07284342 ·Status: RECRUITING

Dopamine Turnover Rate as Surrogate Parameter for Diagnosis of Early Parkinson's Disease

NCT00153972 ·Status: COMPLETED ·Phase: PHASE4

Long-term Safety and Effectiveness of Levodopa-carbidopa Intestinal Gel Infusion

NCT03602924 ·Status: UNKNOWN

Efficacy and Safety of Entacapone Combined With Madopar in the Treatment of Early Parkinson's Disease: An Observational, Multicenter, Case-Control Study

NCT06928519 ·Status: RECRUITING

Study on Practical ExperienceS of Treatment With Foslevodopa/foScaRbidopa in Advanced Parkinson's Disease

NCT06937034 ·Status: RECRUITING

Basic and Clinical Studies of Levodopa/Carbidopa/Entacapone in the Treatment of Early Parkinson's Disease

NCT06236230 ·Status: RECRUITING ·Phase: PHASE4

Common Noradrenergic Mechanisms in Parkinson´s Disease and L-DOPA Induced Dyskinesia

NCT02578849 ·Status: UNKNOWN

Patient- and Caregiver-reported Symptoms and Outcomes With Levodopa/Carbidopa Intestinal Gel for the Treatment of Advanced Parkinson's Disease

NCT02289729 ·Status: COMPLETED

Augmenting Effects of L-DOPS With Carbidopa and Entacapone

NCT00547911 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

An Open-Label Feasibility/Pilot Study With [123I]-IBZM SPECT (DOPA-SYN)

NCT00200447 ·Status: COMPLETED ·Phase: PHASE2

DESENSITIZE-PD: Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Support Dopaminergic Desensitization in PD

NCT05579379 ·Status: UNKNOWN

Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers

NCT00415740 ·Status: COMPLETED ·Phase: PHASE1

PharmacoMRI of Parkinson Disease

NCT01528592 ·Status: COMPLETED ·Phase: NA

[11C]Donepezil PET For Imaging The Autonomous Nervous System In Parkinsons Disease

NCT02012595 ·Status: COMPLETED

Long-Term Dopamine Transporter Imaging and Clinical Assessment of Parkinson's Disease Progression

NCT00134784 ·Status: COMPLETED ·Phase: PHASE2

A Pharmacokinetic Study of Levodopa and Carbidopa Intestinal Gel in Subjects With Advanced Parkinson's Disease

NCT01484990 ·Status: COMPLETED ·Phase: PHASE1

Assessing Imaging as a Tool in Monitoring and Predicting the Progression of Parkinson Disease

NCT00404170 ·Status: COMPLETED ·Phase: PHASE2

Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers

NCT00415922 ·Status: COMPLETED ·Phase: PHASE1

Monitoring of Mobility of Parkinson's Patients for Therapeutic Purposes - Clinical Trial

NCT04176302 ·Status: COMPLETED ·Phase: NA

Metformin in Parkinson Disease

NCT07229651 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease

NCT00335153 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetic Study in Healthy Volunteers

NCT02554734 ·Status: COMPLETED ·Phase: PHASE1